中文字幕亚洲专区,日本不卡久久,国产女同一区

熱門搜索化學(xué)品最多只顯示前20條，請(qǐng)點(diǎn)擊“搜索化學(xué)品”查看所有結(jié)果

CAS登錄號(hào)

中文名

英文名

分子結(jié)構(gòu)式

分子式

詳情

供應(yīng)商

13190-97-1

茄尼醇;
茄呢醇;
九聚異戌二烯醇

Solanesol;
3,7,11,15,19,23,27,31,35-Nonamethylhexatriaconta-2,6,10,14,18,22,26,30,34-nonaen-1-ol

Cereulide (9CI);
1,7,13,19,25,31-Hexaoxa-4,10,16,22,28,34-hexaazacyclohexatriacontane,cyclic peptide deriv.;
Cyclo(D-alanyl-3-methyl-L-2-hydroxybutanoyl-L-valyl-4-methyl-D-2-hydroxypentanoyl-D-alanyl-3-methyl-L-2-hydroxybutanoyl-L-valyl-4-methyl-D-2-hydroxypentanoyl-D-alanyl-3-methyl-L-2-hydroxybutanoyl-L-valyl-4-methyl-D-2-hydroxypentanoyl)

enantio-Valinomycin(8CI,9CI);
1,7,13,19,25,31-Hexaoxa-4,10,16,22,28,34-hexaazacyclohexatriacontane,cyclic peptide deriv.;
Cyclo(L-a-hydroxyisovaleryl-L-valyl-D-lactoyl-D-valyl-L-a-hydroxyisovaleryl-L-valyl-D-lactoyl-D-valyl-L-a-hydroxyisovaleryl-L-valyl-D-lactoyl-D-valyl)

enantio-pseudo-retro-Valinomycin(8CI,9CI);
1,7,13,19,25,31-Hexaoxa-4,10,16,22,28,34-hexaazacyclohexatriacontane,cyclic peptide deriv.;
Cyclo(D-alanyl-L-a-hydroxyisovaleryl-L-valyl-D-a-hydroxyisovaleryl-D-alanyl-L-a-hydroxyisovaleryl-L-valyl-D-a-hydroxyisovaleryl-D-alanyl-L-a-hydroxyisovaleryl-L-valyl-D-a-hydroxyisovaleryl);
Cyclo(D-a-hydroxyisovaleryl-D-alanyl-L-a-hydroxyisovaleryl-L-valyl-D-a-hydroxyisovaleryl-D-alanyl-L-a-hydroxyisovaleryl-L-valyl-D-a-hydroxyisovaleryl-D-alanyl-L-a-hydroxyisovaleryl-L-valyl)

enantio-retro-Valinomycin(8CI,9CI);
1,7,13,19,25,31-Hexaoxa-4,10,16,22,28,34-hexaazacyclohexatriacontane,cyclic peptide deriv.;
Cyclo(L-a-hydroxyisovaleryl-D-valyl-D-lactoyl-L-valyl-L-a-hydroxyisovaleryl-D-valyl-D-lactoyl-L-valyl-L-a-hydroxyisovaleryl-D-valyl-D-lactoyl-L-valyl)

Fusigen (8CI,9CI);
1,13,25-Trioxa-7,19,31-triazacyclohexatriaconta-9,21,33-triene-2,8,14,20,26,32-hexone,3,15,27-triamino-7,19,31-trihydroxy-10,22,34-trimethyl-, iron complex;
1,13,25-Trioxa-7,19,31-triazacyclohexatriacontane, fusigen deriv.;
Ferricfusarinine C;
Fusarinine C;
Stereoisomer of[3,15,27-triamino-7,19,31-trihydroxy-10,22,34-trimethyl-1,13,25-trioxa-7,19,31-triazacyclohexatriaconta-9,21,33-triene-2,8,14,20,26,32-hexonato(3-)-O7,O8,O19,O20,O31,O32]iron

Fusigen, deferri- (9CI);
1,13,25-Trioxa-7,19,31-triazacyclohexatriacontane,fusigen deriv.;
1,13,25-Trioxa-7,19,31-triazacyclohexatriaconta-9,21,33-triene-2,8,14,20,26,32-hexone,3,15,27-triamino-7,19,31-trihydroxy-10,22,34-trimethyl-,[3S-(3R*,9Z,15R*,21Z,27R*,33Z)]-;
Deferrifusigen;
Desferifusigen;
NSC 295380;
[3S-(3R*,9Z,15R*,21Z,27R*,33Z)]-3,15,27-Triamino-7,19,31-trihydroxy-10,22,34-trimethyl-1,13,25-trioxa-7,19,31-triazacyclohexatriaconta-9,21,33-triene-2,8,14,20,26,32-hexone

正三十六烷;
三十六烷;
正三十六烷

hexatriacontane;
NSC 407536;
n-hexatriacontane

pseudo-Valinomycin(8CI,9CI);
1,7,13,19,25,31-Hexaoxa-4,10,16,22,28,34-hexaazacyclohexatriacontane,pseudo-valinomycin deriv.;
Cyclo(D-a-hydroxyisovaleryl-L-alanyl-L-a-hydroxyisovaleryl-D-valyl-D-a-hydroxyisovaleryl-L-alanyl-L-a-hydroxyisovaleryl-D-valyl-D-a-hydroxyisovaleryl-L-alanyl-L-a-hydroxyisovaleryl-D-valyl);
Cyclo(L-alanyl-L-a-hydroxyisovaleryl-D-valyl-D-a-hydroxyisovaleryl-L-alanyl-L-a-hydroxyisovaleryl-D-valyl-D-a-hydroxyisovaleryl-L-alanyl-L-a-hydroxyisovaleryl-D-valyl-D-a-hydroxyisovaleryl)

Piperazine,1,1'-(1,36-dioxo-1,36-hexatriacontanediyl)bis[4-(3,3,5-trimethyl-1-cyclohexen-1-yl)-(9CI);
TU 0131

pseudo-retro-Valinomycin(8CI,9CI);
1,7,13,19,25,31-Hexaoxa-4,10,16,22,28,34-hexaazacyclohexatriacontane,pseudo-retro-valinomycin deriv.;
Cyclo(L-alanyl-D-a-hydroxyisovaleryl-D-valyl-L-a-hydroxyisovaleryl-L-alanyl-D-a-hydroxyisovaleryl-D-valyl-L-a-hydroxyisovaleryl-L-alanyl-D-a-hydroxyisovaleryl-D-valyl-L-a-hydroxyisovaleryl);
Cyclo(L-a-hydroxyisovaleryl-L-alanyl-D-a-hydroxyisovaleryl-D-valyl-L-a-hydroxyisovaleryl-L-alanyl-D-a-hydroxyisovaleryl-D-valyl-L-a-hydroxyisovaleryl-L-alanyl-D-a-hydroxyisovaleryl-D-valyl)

1,18-Diazoniatricyclo[29.3.1.114,18]hexatriaconta-1(35),14,16,18(36),31,33-hexaene;
1,18-Diazatricyclo[29.3.1.114,18]hexatriacontane,1,18-diazoniatricyclo[29.3.1.114,18]hexatriaconta-1(35),14,16,18(36),31,33-hexaenederiv.;
Cyclostellettamine A;
MS 1620B2A1D

17-hexatriacontanol;
hexatriacontan-17-ol

纈氨霉素

Valinomycin;
1,7,13,19,25,31-Hexaoxa-4,10,16,22,28,34-hexaazacyclohexatriacontane-2,5,8,11,14,17,20,23,26,29,32,35-dodecone,3,6,9,15,18,21,27,30,33-nonaisopropyl-12,24,36-trimethyl- (7CI);
1,7,13,19,25,31-Hexaoxa-4,10,16,22,28,34-hexaazacyclohexatriacontane, cyclicpeptide deriv.;
Cyclo(D-a-hydroxyisovaleryl-D-valyl-L-lactoyl-L-valyl-D-a-hydroxyisovaleryl-D-valyl-L-lactoyl-L-valyl-D-a-hydroxyisovaleryl-D-valyl-L-lactoyl-L-valyl);
NSC 122023;
Valinomicin

1,4-Dioxacyclohexatriacontane-2-methanol,7,11,15,19,22,26,30,34-octamethyl-;
1,2-Cyclic-diphytanylglycerol ether

3,6,9,12,15,18-Hexaoxahexatriacontan-1-ol;
Ethanol,2-[2-[2-[2-[2-[2-(octadecyloxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]-;
Hexa(ethylene glycol) octadecyl ether;
Hexaethyleneglycol monooctadecyl ether

輔酶Q9

COENZYME Q9;
COENZYME Q9;
UBIQUINONE-45;
UBIQUINONE-9;
,6,10,14,18,22,26,30,34-hexatriacontanonaenyl)-;
coenzymeq(sub9);
coq(sub9);
p-benzoquinone,2,3-dimethoxy-5-methyl-6-(3,7,11,15,19,23,27,31,35-nonamethyl-2;
ubiquinoneq(sub9)

C54H82O4

詳情

供應(yīng)商

化工產(chǎn)品